Steven Le Gouill, MD, PhD¹, Virginie de Wilde^2*, Toby A. Eyre^3,4*, Mary B. Callanan, PhD^5*, Gandhi Damaj, MD, PhD^6*, Alexis Claudel^7*, Adrien Chauchet^8*, Roch Houot, MD, PhD^9*, Ronan Le Calloch^10*, Victoria Cacheux^11*, Marc André, MD, PhD^12*, Franck Morschhauser¹³, Barbara Burroni, MD^14*, David John Lewis, PhD, BSc, BSc, FRCPath^15*, Benoit Tessoulin^16* and Aurore Touzart, MD, PhD^17,18*

¹Hematology Department, Institut Curie, Paris, France
²Hôpital Erasme, +université libre de Bruxelles, Bruxelles, Belgium
³Oxford University Hospitals NHS Trust, Oxford, United Kingdom
⁴Churchill Hospital, Oxford University, Oxford, United Kingdom
⁵CHU de Dijon, Université de Bourgogne, Dijon, France
⁶Hematology Institute, University Of Caen Normandie Hospital Center, Caen, France
⁷Hemato-biology, Henri Mondor University Hospital, CRETEIL, France
⁸Besançon University Hospital, Besançon, France
⁹Clinical Hematology, INSERM U1236, EFS, Hopital Pontchaillou, Rennes University Hospital, Rennes, France
¹⁰centre hospitalier de Cornouaille, quimper, France
¹¹CHU Estaing, Clermont Ferrand, France
¹²CHU UCL Namur, Yvoir, Belgium
¹³Centre Hospitalier Universitaire de Lille - Hopital Claude Huriez, Lille, France
¹⁴Department of Pathology, Hôpital Cochin, Université de Paris, APHP, Paris, France
¹⁵University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom
¹⁶Hematology Department, CHU Nantes, Nantes, France
¹⁷Laboratory of Onco-Hematology, Necker Enfants-Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
¹⁸INSERM U1151, Institut Necker Enfants Malades (INEM), Paris, France

Jia Ruan, MD, PhD¹, David A. Bond, MD, BS², Bijal D Shah, MD³, John N. Allan, MD¹, Sarah C. Rutherford, MD¹, Caitlin Gribbin, MD^1*, Zhengming Chen, PhD^4*, Brittany Hobbie^1*, Melinda Harbhajan^1*, Tejasvi Sahni^1*, Wayne Tam, MD, PhD⁵, Bhavneet Bhinder^4*, Michael Sigouros^4*, Giorgio Inghirami, MD^6*, Selina Chen-Kiang, PhD⁷, Olivier Elemento, PhD, MS, BS⁸, Kami J. Maddocks, MD², John P. Leonard, MD⁴ and Peter Martin, MD¹

¹Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
²Division of Hematology, The Ohio State University, Columbus, OH
³Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁴Weill Cornell Medicine, New York, NY
⁵Northwell Health, New York
⁶Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY
⁷Weill-Cornell Medical College, New York, NY
⁸Englander Institute for Precision Medicine/ Weill Cornell Medicine, Weill Cornell Medicine, New York, NY

Mats Jerkeman, MD, PhD¹, Karin Fahl Wader, MD, PhD^2*, Ingrid Glimelius, MD, PhD³, Annika Pasanen, MD, PhD^4*, Wonseog KIM, MD, PhD^5*, Louise Krüger Hansen^6*, Jon Riise, MD, PhD^7*, Martin Hutchings, MD, PhD⁸, Hashim Hussein Elhussein^9*, Carsten Utoft Niemann, MD, PhD^10*, Rasmus Rask Kragh Jørgensen, MSc^11*, Tarec Christoffer El-Galaly, MD, DMSc, Prof¹², Mats Ehinger, MD, PhD^13*, Klaus Beiske, MD, PhD^14*, Rose-Marie Amini^15*, Michael Boe Møller^16*, Marja-Liisa Karjalainen-Lindsberg, MD, PhD^17* and Jacob Haaber Christensen, MD, PhD^18*

¹Division of Oncology, Skane University Hospital and Lund University, Lund, Sweden
²St Olav University Hospital, Department of Oncology, Trondheim, Norway
³Department of Immunology, Genetics and Pathology, Cancer Precision Medicine Unit, Uppsala University, Uppsala, Sweden., Uppsala University, Uppsala, Sweden
⁴Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
⁵Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea, Republic of (South)
⁶Aarhus University, Aarhus, Denmark
⁷Department of Oncology, Oslo University Hospital, Oslo, NOR
⁸Rigshospitalet and University of Copenhagen, Copenhagen, Denmark
⁹Rigshospitalet, Copenhagen, Denmark
¹⁰Department of Clinical Medicine, Dept. of Hematology, Rigshospitalet, Copenhagen, Denmark, Copenhagen, Denmark
¹¹University of Aalborg, Aalborg, Denmark
¹²Department of Hematology, Aalborg Hospital, Aalborg, Denmark
¹³Lund University, Lund, SWE
¹⁴Oslo University Hospital, Oslo, Norway
¹⁵Department of Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden
¹⁶Pathology, Odense University Hospital, Odense, Denmark
¹⁷Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
¹⁸Dept. of Hematology, Odense University Hospital, Odense, Denmark

Tom Van Meerten^1*, M.J. Kersten, MD, PhD^2*, Gloria Iacoboni, MD^3*, Georg Hess, MD^4*, Pim Mutsaers, MD^5*, Alejandro Martin Garcia-Sancho^6*, Andre Goy, MD, MS⁷, Eva Gine, MD⁸, Brian T. Hill, MD⁹, Wen-Kai Weng, MD, PhD¹⁰, Martin Dreyling, MD¹¹, Patrick M. Reagan, MD¹², Krish Patel, MD^13*, Ahmed Galal, MD, MSc, FRCPC^14*, Charles Herbaux, MD, PhD^15*, Robin Sanderson, FRCPath, PhD¹⁶, Dan Zheng, PhD^17*, Justyna Kanska, PhD^17*, Wangshu Zhang, PhD^17*, Rita Damico Khalid, DO^17*, Ioana Kloos, MD, FRCPC^17* and Michael Wang, MD¹⁸

¹Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
²Location University of Amsterdam, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
³Vall d’Hebron University Hospital, Barcelona, Spain
⁴Johannes Gutenberg-Universität Mainz, Mainz, Germany
⁵Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
⁶Hematology Department, Salamanca University Hospital, IBSAL, CIBERONC, Salamanca, Spain
⁷John Theurer Cancer Center, Hackensack, NJ
⁸Hospital Clínic of Barcelona, IDIBAPS, CIBERONC, Barcelona, Spain
⁹Cleveland Clinic Foundation, Cleveland, OH
¹⁰Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
¹¹Department of Medicine III, Ludwig Maximilian University Hospital, Munich, Germany
¹²University of Rochester Medical Center, Rochester, NY
¹³Swedish Cancer Institute, Seattle, WA
¹⁴Carol G. Simon Cancer Center, Morristown, NJ
¹⁵Hématologie Clinique, CHU Montpellier, Montpellier, France
¹⁶King’s College Hospital, London, United Kingdom
¹⁷Kite, a Gilead Company, Santa Monica, CA
¹⁸The University of Texas MD Anderson Cancer Center, Houston, TX

Yasmina I.M. Serroukh^1*, Mathilde Fekom^2*, Irma Khvedelidze^2*, Ben Carpenter, MD^3*, Herve Ghesquieres, MD, PhD^4*, Ludovic Gabellier, MD, PhD^5*, Jacques-Olivier Bay, MD, PhD^6*, Didier Blaise, MD^7*, Maurizio Musso^8*, Patrice Chevallier, MD, PhD⁹, Edouard Forcade, MD, PhD^10*, Anne Huynh, MD^11*, Andy Peniket^12*, Marek Trněný, MD, CSc¹³, Catherine Flynn^14*, Shankara Paneesha^15*, Andrew Clark^16*, Charalampia Kyriakou, MD, PhD¹⁷, Anna Ossami Saidy^18*, Bertram Glass, MD^18*, Luca Castagna^19*, Silvia Montoto, MD²⁰ and Ali Bazarbachi, MD, PhD²¹

¹Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Leuven, Belgium
²European Bone Marrow Transplantation Lymphoma Working Party, Paris, France
³University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁴Hospices Civils de Lyon, Lyon, France
⁵Hematology Departement, CHU Montpellier University Hospital, UMR-CNRS 5535, Montpellier, France
⁶CHU ESTAING, Clermont-Ferrand, France
⁷Programme de Transplantation & Therapie Cellulaire, Marseille, France
⁸Hematology Unit, Clinica La Maddalena Division of Onco-Hematology and Stem Cell Transplantation, Palermo, Italy
⁹CHU de Nantes, Nantes, France
¹⁰Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Bordeaux, France
¹¹Hematology Department, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
¹²Oxford Radcliffe, Oxford, United Kingdom
¹³Charles University Hospital, Prague, Czech Republic
¹⁴Department of Haematology, St. James' Hospital, Dublin, Ireland
¹⁵Birmingham Centre for Cellular Therapy and Transplant (BCCTT), Birmingham, United Kingdom
¹⁶Glasgow Royal Infirmary, Glasgow, United Kingdom
¹⁷Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹⁸Department of Hematology and Cell Therapy, Helios Klinikum Berlin-Buch, Berlin, Germany
¹⁹Bone Marrow Transplantation Unit AOR Villa Sofia Cervello, Palermo, Italy
²⁰St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom
²¹American University of Beirut Dept. of Medicine, Beirut, Lebanon

Christopher Melani, MD¹, Rahul Lakhotia, MBBS¹, Stefania Pittaluga, MD, PhD^2*, James D. Phelan, PhD^1*, Jagan R. Muppidi, MD, PhD^3*, Max J Gordon, MD^1*, Yandan Yang, PhD^1*, Weihong Xu^1*, Theresa Davies-Hill^2*, Da Wei Huang, MD^1*, Craig J. Thomas, PhD^4*, Michele Ceribelli, PhD^4*, Frances A Tosto^4*, Anna M Juanitez, RN^1*, Amynah Pradhan, NP^1*, Candis Morrison, NP, PhD^1*, Atekelt Tadese, PA^1*, Colleen Ramsower, BS, MB^5*, Lisa M. Rimsza, MD⁵, Allison P. Jacob, MSc⁶, Heidi Simmons, PhD⁶, Seth M. Steinberg, PhD^7*, Elaine S. Jaffe, MD⁸, Mark Roschewski, MD⁹, Louis M. Staudt, MD, PhD¹⁰ and Wyndham H Wilson, MD, PhD^1*

¹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
²Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
³Lymphoid Malignancies Branch, National Institutes of Health, Bethesda, MD
⁴Division of Pre-Clinical Innovation Chemistry Technologies, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD
⁵Department of Pathology and Laboratory Medicine, The University of Arizona, Tucson, AZ
⁶Adaptive Biotechnologies, Seattle, WA
⁷National Cancer Institute, National Institutes of Health, Bethesda, MD
⁸Laboratory of Pathology, Clinical Center, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁹NIH/NIC, Bethesda, MD
¹⁰Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD